We are live on ! Find out more
LCM

Lynx1 Capital Management Portfolio holdings

AUM $633M
1-Year Est. Return 173.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+173.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$491M
AUM Growth
+$145M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$25.9M
2
+$10M
3
+$4.18M
4
DNLI icon
Denali Therapeutics
DNLI
+$3.76M
5
PASG icon
Passage Bio
PASG
+$1.12M

Top Sells

1
+$12.5M
2
+$2.41M
3
+$2.26M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$1.88M
5
IBIO icon
iBio
IBIO
+$371K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$144M 29.4%
1,534,141
-34,700
2
$110M 22.37%
5,404,674
3
$104M 21.23%
8,601,189
+1,854,238
4
$46.5M 9.47%
700,014
-33,000
5
$34.2M 6.96%
5,766,090
+1,365,248
6
$15.8M 3.21%
7,098,133
7
$14.3M 2.91%
7,857,347
8
$5.76M 1.17%
1,042,596
+6,545
9
$5.3M 1.08%
+1,325,848
10
$5.01M 1.02%
623,704
+160,856
11
$3.8M 0.77%
+261,687
12
$874K 0.18%
1,055,897
-482,676
13
$677K 0.14%
546,119
-10,510,890
14
$497K 0.1%
65,954
15
– –
-10,366
16
– –
-219,247
17
– –
-45,806